Consolidated Statement of Operations - USD ($)	3 Months Ended
	Jan. 31, 2019	Jan. 31, 2018
Details
Revenues	$ 3,656,124	$ 3,513,487
Cost of expenses:
Cost of revenues	2,032,420	2,239,299
Research and development expenses	143,955	154,666
Selling, general, and administrative expenses	2,245,897	2,220,828
Operating Expenses	4,422,272	4,614,793
Loss from operations	(766,148)	(1,101,306)
Interest expense - related party	167,919	65,713
Loss before income taxes	(934,067)	(1,167,019)
Provision for income taxes	0	0
Net loss	$ (934,067)	$ (1,167,019)
Net loss per common share - basic	$ (0.12)	$ (0.15)
Net loss per common share - diluted	$ (0.12)	$ (0.15)
Weighted average number of common shares outstanding - basic	7,696,091	7,696,091
Weighted average number of common shares outstanding - diluted	7,696,091	7,696,091